What is the proper use of Enlyte?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Enlyte: Proper Use and Clinical Application

Enlyte is a medical food/prescription supplement containing L-methylfolate, methylcobalamin (B12), and pyridoxal-5-phosphate (B6), primarily indicated for nutritional management of conditions associated with folate deficiency or impaired folate metabolism, though no specific guideline evidence addresses this product directly.

Critical Context

The provided evidence focuses exclusively on enteral nutrition (EN) and parenteral nutrition (PN) in hospitalized patients with kidney disease, inflammatory bowel disease, critical illness, and chronic intestinal failure 1. None of this evidence addresses Enlyte or similar oral vitamin/folate supplements used in outpatient settings.

What the Evidence Does NOT Support

The guidelines provided discuss:

  • Enteral feeding formulas for hospitalized patients with renal failure, requiring disease-specific formulas with reduced electrolytes 1
  • Nutritional support timing in critically ill patients, recommending early EN within 48 hours 1
  • Protein and energy requirements in kidney disease (0.55-0.60 g/kg/day protein for CKD) 1
  • Contraindications to enteral feeding including ileus, intestinal obstruction, and severe shock 1, 2

Evidence on Supplements NOT Applicable to Enlyte

  • Omega-3 fatty acids are NOT recommended for IBS or inflammatory conditions 3
  • Glutamine supplementation is NOT recommended in critically ill patients with kidney disease 1
  • Probiotics have limited evidence for intestinal rehabilitation 1

Clinical Pitfall

The question asks about "Enlyte" but the evidence base provided addresses hospital-based enteral/parenteral nutrition, not outpatient oral vitamin supplementation. These are fundamentally different interventions for different patient populations and clinical contexts.

General Medical Knowledge Application

Enlyte-type products (L-methylfolate combinations) are typically used for:

  • Depression with MTHFR polymorphisms affecting folate metabolism
  • Hyperhomocysteinemia management
  • Nutritional support in patients on medications affecting folate metabolism (methotrexate, antiepileptics)

Standard dosing follows manufacturer recommendations, typically one capsule daily, as no guideline-level evidence exists for this specific medical food product.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

NPO Management in Ileus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Post-Infectious IBS Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.